

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | pyrimidine nucleobase catabolic process (GO:0006208) | 5.11324404 |
| 2 | nucleobase catabolic process (GO:0046113) | 4.31252781 |
| 3 | neuron cell-cell adhesion (GO:0007158) | 4.30394785 |
| 4 | gamma-aminobutyric acid transport (GO:0015812) | 4.27916545 |
| 5 | protein localization to cilium (GO:0061512) | 4.04348054 |
| 6 | presynaptic membrane assembly (GO:0097105) | 4.03401033 |
| 7 | presynaptic membrane organization (GO:0097090) | 3.88823047 |
| 8 | behavioral response to nicotine (GO:0035095) | 3.80824949 |
| 9 | postsynaptic membrane organization (GO:0001941) | 3.77440164 |
| 10 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.73165452 |
| 11 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 3.58411254 |
| 12 | regulation of synapse structural plasticity (GO:0051823) | 3.57074445 |
| 13 | vocalization behavior (GO:0071625) | 3.49723448 |
| 14 | synapse assembly (GO:0007416) | 3.49501164 |
| 15 | positive regulation of mitochondrial fission (GO:0090141) | 3.48653123 |
| 16 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.45156927 |
| 17 | auditory behavior (GO:0031223) | 3.34189302 |
| 18 | synaptic vesicle maturation (GO:0016188) | 3.32566503 |
| 19 | nonmotile primary cilium assembly (GO:0035058) | 3.32342294 |
| 20 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.30407540 |
| 21 | synaptic vesicle exocytosis (GO:0016079) | 3.28531544 |
| 22 | glycosphingolipid biosynthetic process (GO:0006688) | 3.28015189 |
| 23 | protein localization to synapse (GO:0035418) | 3.26788480 |
| 24 | synaptic transmission, glutamatergic (GO:0035249) | 3.25823013 |
| 25 | glutamate receptor signaling pathway (GO:0007215) | 3.20499826 |
| 26 | sequestering of actin monomers (GO:0042989) | 3.19838270 |
| 27 | neuronal action potential propagation (GO:0019227) | 3.19604972 |
| 28 | epithelial cilium movement (GO:0003351) | 3.13730799 |
| 29 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.09556155 |
| 30 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339) | 3.09074961 |
| 31 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.07996980 |
| 32 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.05236079 |
| 33 | glutamate secretion (GO:0014047) | 3.02654549 |
| 34 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.00509425 |
| 35 | platelet dense granule organization (GO:0060155) | 2.99575051 |
| 36 | neuron-neuron synaptic transmission (GO:0007270) | 2.97321526 |
| 37 | transmission of nerve impulse (GO:0019226) | 2.97118571 |
| 38 | neurotransmitter secretion (GO:0007269) | 2.92605917 |
| 39 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.91022378 |
| 40 | regulation of synaptic vesicle transport (GO:1902803) | 2.90532365 |
| 41 | axonal fasciculation (GO:0007413) | 2.88557264 |
| 42 | regulation of cilium movement (GO:0003352) | 2.88122195 |
| 43 | dendritic spine morphogenesis (GO:0060997) | 2.87996737 |
| 44 | startle response (GO:0001964) | 2.87236427 |
| 45 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.84256079 |
| 46 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.82726472 |
| 47 | response to auditory stimulus (GO:0010996) | 2.81379382 |
| 48 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.79140473 |
| 49 | regulation of respiratory system process (GO:0044065) | 2.77751331 |
| 50 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.74156530 |
| 51 | cilium movement (GO:0003341) | 2.73591076 |
| 52 | neuron recognition (GO:0008038) | 2.72539285 |
| 53 | establishment of mitochondrion localization (GO:0051654) | 2.72241379 |
| 54 | regulation of feeding behavior (GO:0060259) | 2.70843010 |
| 55 | neuronal action potential (GO:0019228) | 2.70024527 |
| 56 | axoneme assembly (GO:0035082) | 2.69847427 |
| 57 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.68727473 |
| 58 | cilium or flagellum-dependent cell motility (GO:0001539) | 2.67059550 |
| 59 | C4-dicarboxylate transport (GO:0015740) | 2.65253225 |
| 60 | neuromuscular synaptic transmission (GO:0007274) | 2.65042426 |
| 61 | cellular ketone body metabolic process (GO:0046950) | 2.63174176 |
| 62 | regulation of neurotransmitter levels (GO:0001505) | 2.62862530 |
| 63 | positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110 | 2.62108758 |
| 64 | mitochondrial outer membrane permeabilization involved in programmed cell death (GO:1902686) | 2.62108758 |
| 65 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.61746530 |
| 66 | positive regulation of synapse assembly (GO:0051965) | 2.58940768 |
| 67 | regulation of action potential (GO:0098900) | 2.58341800 |
| 68 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.56785696 |
| 69 | mechanosensory behavior (GO:0007638) | 2.55057947 |
| 70 | cilium morphogenesis (GO:0060271) | 2.54767560 |
| 71 | cilium assembly (GO:0042384) | 2.52812978 |
| 72 | neural tube formation (GO:0001841) | 2.52285617 |
| 73 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.52091813 |
| 74 | cilium organization (GO:0044782) | 2.51938879 |
| 75 | response to dietary excess (GO:0002021) | 2.51502483 |
| 76 | synapse organization (GO:0050808) | 2.51202992 |
| 77 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.50957841 |
| 78 | synaptic transmission, cholinergic (GO:0007271) | 2.49971201 |
| 79 | detection of light stimulus involved in visual perception (GO:0050908) | 2.49628203 |
| 80 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.49628203 |
| 81 | glycerophospholipid catabolic process (GO:0046475) | 2.49616818 |
| 82 | proline transport (GO:0015824) | 2.47637201 |
| 83 | intraciliary transport (GO:0042073) | 2.47541464 |
| 84 | regulation of neurotransmitter uptake (GO:0051580) | 2.47495464 |
| 85 | protein neddylation (GO:0045116) | 2.47249559 |
| 86 | membrane depolarization during action potential (GO:0086010) | 2.46285328 |
| 87 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.43860849 |
| 88 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.43860849 |
| 89 | protein-cofactor linkage (GO:0018065) | 2.42656689 |
| 90 | adult walking behavior (GO:0007628) | 2.42203218 |
| 91 | regulation of collateral sprouting (GO:0048670) | 2.41069679 |
| 92 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.40540468 |
| 93 | neurotransmitter metabolic process (GO:0042133) | 2.40400829 |
| 94 | retinal ganglion cell axon guidance (GO:0031290) | 2.40275017 |
| 95 | positive regulation of amino acid transport (GO:0051957) | 2.39778952 |
| 96 | serotonin metabolic process (GO:0042428) | 2.39362595 |
| 97 | adult behavior (GO:0030534) | 2.38802635 |
| 98 | retinal cone cell development (GO:0046549) | 2.38564843 |
| 99 | regulation of neurotransmitter transport (GO:0051588) | 2.38272391 |
| 100 | axon ensheathment in central nervous system (GO:0032291) | 2.37581152 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.29533688 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.39287628 |
| 3 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.95123008 |
| 4 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.76338267 |
| 5 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.75806381 |
| 6 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.69796674 |
| 7 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.69301786 |
| 8 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.65939742 |
| 9 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.46494236 |
| 10 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.41150631 |
| 11 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.39742761 |
| 12 | VDR_22108803_ChIP-Seq_LS180_Human | 2.21763280 |
| 13 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 2.09474823 |
| 14 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.07936984 |
| 15 | P300_19829295_ChIP-Seq_ESCs_Human | 1.96368902 |
| 16 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.88279867 |
| 17 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.84354781 |
| 18 | FUS_26573619_Chip-Seq_HEK293_Human | 1.83835389 |
| 19 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.80338412 |
| 20 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.76786163 |
| 21 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.74948896 |
| 22 | EWS_26573619_Chip-Seq_HEK293_Human | 1.73506739 |
| 23 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.73129209 |
| 24 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.67041606 |
| 25 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.66274726 |
| 26 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.66110395 |
| 27 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.63668150 |
| 28 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.60490053 |
| 29 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.59774930 |
| 30 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.58716019 |
| 31 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.58194628 |
| 32 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.54301745 |
| 33 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.51233750 |
| 34 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.48850378 |
| 35 | AR_25329375_ChIP-Seq_VCAP_Human | 1.48217614 |
| 36 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.48150494 |
| 37 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.44318440 |
| 38 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.43938725 |
| 39 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.43682093 |
| 40 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.43363693 |
| 41 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.41435296 |
| 42 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.41007365 |
| 43 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.40838501 |
| 44 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.40744135 |
| 45 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.39153563 |
| 46 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.38062072 |
| 47 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.38062072 |
| 48 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.37866400 |
| 49 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.36344945 |
| 50 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.33666706 |
| 51 | STAT3_23295773_ChIP-Seq_U87_Human | 1.32561341 |
| 52 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.30982831 |
| 53 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.30109574 |
| 54 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.28005625 |
| 55 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.28005625 |
| 56 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.27773200 |
| 57 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.27005139 |
| 58 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.25939330 |
| 59 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.25575717 |
| 60 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.24166475 |
| 61 | TCF4_23295773_ChIP-Seq_U87_Human | 1.23830646 |
| 62 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.23479758 |
| 63 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.22604565 |
| 64 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.22235453 |
| 65 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.21942472 |
| 66 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.20308523 |
| 67 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.20258461 |
| 68 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.19324654 |
| 69 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.18154078 |
| 70 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.17995964 |
| 71 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.17554604 |
| 72 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.15432551 |
| 73 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.14439248 |
| 74 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.12964621 |
| 75 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.12611903 |
| 76 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.12266995 |
| 77 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.10902637 |
| 78 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.08979835 |
| 79 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.08828159 |
| 80 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.08734010 |
| 81 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.08466837 |
| 82 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.08466837 |
| 83 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.08327006 |
| 84 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.07136635 |
| 85 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.07003041 |
| 86 | JUN_21703547_ChIP-Seq_K562_Human | 1.05448925 |
| 87 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.04706430 |
| 88 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.04335049 |
| 89 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.03450094 |
| 90 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.03306219 |
| 91 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.03148441 |
| 92 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.02198810 |
| 93 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.01878014 |
| 94 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.01470197 |
| 95 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.01240337 |
| 96 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.00946459 |
| 97 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.00668410 |
| 98 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.97161494 |
| 99 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.94595486 |
| 100 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.94421777 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003880_abnormal_central_pattern | 3.75117435 |
| 2 | MP0004859_abnormal_synaptic_plasticity | 3.04502709 |
| 3 | MP0004270_analgesia | 2.68588872 |
| 4 | MP0009046_muscle_twitch | 2.68439527 |
| 5 | MP0009745_abnormal_behavioral_response | 2.58389568 |
| 6 | MP0001984_abnormal_olfaction | 2.53483695 |
| 7 | MP0005423_abnormal_somatic_nervous | 2.50824640 |
| 8 | MP0003635_abnormal_synaptic_transmissio | 2.44743591 |
| 9 | MP0001968_abnormal_touch/_nociception | 2.44736824 |
| 10 | MP0002272_abnormal_nervous_system | 2.38212738 |
| 11 | MP0002064_seizures | 2.33913392 |
| 12 | MP0002102_abnormal_ear_morphology | 2.30290409 |
| 13 | MP0002735_abnormal_chemical_nociception | 2.30201378 |
| 14 | MP0001529_abnormal_vocalization | 2.27154593 |
| 15 | MP0001486_abnormal_startle_reflex | 2.25577737 |
| 16 | MP0002822_catalepsy | 2.23596699 |
| 17 | MP0002638_abnormal_pupillary_reflex | 2.19673033 |
| 18 | MP0002063_abnormal_learning/memory/cond | 2.18319477 |
| 19 | MP0002572_abnormal_emotion/affect_behav | 2.14024905 |
| 20 | MP0002736_abnormal_nociception_after | 2.13491730 |
| 21 | MP0003787_abnormal_imprinting | 2.11153241 |
| 22 | MP0006276_abnormal_autonomic_nervous | 2.04770613 |
| 23 | MP0002734_abnormal_mechanical_nocicepti | 2.03158795 |
| 24 | MP0001970_abnormal_pain_threshold | 1.85602280 |
| 25 | MP0005551_abnormal_eye_electrophysiolog | 1.84833083 |
| 26 | MP0000778_abnormal_nervous_system | 1.84160192 |
| 27 | MP0004142_abnormal_muscle_tone | 1.80816815 |
| 28 | MP0002653_abnormal_ependyma_morphology | 1.74402696 |
| 29 | MP0001501_abnormal_sleep_pattern | 1.73009620 |
| 30 | MP0000569_abnormal_digit_pigmentation | 1.72695050 |
| 31 | MP0005645_abnormal_hypothalamus_physiol | 1.70291953 |
| 32 | MP0002733_abnormal_thermal_nociception | 1.70182325 |
| 33 | MP0002909_abnormal_adrenal_gland | 1.70112908 |
| 34 | MP0002557_abnormal_social/conspecific_i | 1.69389362 |
| 35 | MP0001905_abnormal_dopamine_level | 1.69296581 |
| 36 | MP0004885_abnormal_endolymph | 1.67452422 |
| 37 | MP0003136_yellow_coat_color | 1.65674634 |
| 38 | MP0002067_abnormal_sensory_capabilities | 1.63411044 |
| 39 | MP0003011_delayed_dark_adaptation | 1.62087702 |
| 40 | MP0005253_abnormal_eye_physiology | 1.60280577 |
| 41 | MP0004133_heterotaxia | 1.55753208 |
| 42 | MP0005386_behavior/neurological_phenoty | 1.52582898 |
| 43 | MP0004924_abnormal_behavior | 1.52582898 |
| 44 | MP0010386_abnormal_urinary_bladder | 1.52442279 |
| 45 | MP0003122_maternal_imprinting | 1.50774290 |
| 46 | MP0008877_abnormal_DNA_methylation | 1.48789956 |
| 47 | MP0006072_abnormal_retinal_apoptosis | 1.41295398 |
| 48 | MP0004742_abnormal_vestibular_system | 1.40368534 |
| 49 | MP0001188_hyperpigmentation | 1.40215368 |
| 50 | MP0001986_abnormal_taste_sensitivity | 1.37394651 |
| 51 | MP0005646_abnormal_pituitary_gland | 1.35856725 |
| 52 | MP0004043_abnormal_pH_regulation | 1.34921754 |
| 53 | MP0002837_dystrophic_cardiac_calcinosis | 1.30979049 |
| 54 | MP0003195_calcinosis | 1.27243764 |
| 55 | MP0004811_abnormal_neuron_physiology | 1.26090412 |
| 56 | MP0002882_abnormal_neuron_morphology | 1.25238700 |
| 57 | MP0000955_abnormal_spinal_cord | 1.25011990 |
| 58 | MP0001502_abnormal_circadian_rhythm | 1.24175788 |
| 59 | MP0002184_abnormal_innervation | 1.18342792 |
| 60 | MP0005394_taste/olfaction_phenotype | 1.17714090 |
| 61 | MP0005499_abnormal_olfactory_system | 1.17714090 |
| 62 | MP0000631_abnormal_neuroendocrine_gland | 1.13467938 |
| 63 | MP0005167_abnormal_blood-brain_barrier | 1.12817127 |
| 64 | MP0003633_abnormal_nervous_system | 1.12758985 |
| 65 | MP0005084_abnormal_gallbladder_morpholo | 1.10167531 |
| 66 | MP0003121_genomic_imprinting | 1.09363765 |
| 67 | MP0008789_abnormal_olfactory_epithelium | 1.08449069 |
| 68 | MP0002229_neurodegeneration | 1.07995129 |
| 69 | MP0005187_abnormal_penis_morphology | 1.07900646 |
| 70 | MP0001485_abnormal_pinna_reflex | 1.07575684 |
| 71 | MP0001440_abnormal_grooming_behavior | 1.05633119 |
| 72 | MP0008875_abnormal_xenobiotic_pharmacok | 1.04776372 |
| 73 | MP0002066_abnormal_motor_capabilities/c | 1.04069532 |
| 74 | MP0008569_lethality_at_weaning | 1.03579710 |
| 75 | MP0000026_abnormal_inner_ear | 1.02211310 |
| 76 | MP0008872_abnormal_physiological_respon | 1.02013848 |
| 77 | MP0002876_abnormal_thyroid_physiology | 1.01804657 |
| 78 | MP0002752_abnormal_somatic_nervous | 0.98768449 |
| 79 | MP0004147_increased_porphyrin_level | 0.97962909 |
| 80 | MP0002928_abnormal_bile_duct | 0.96440618 |
| 81 | MP0002751_abnormal_autonomic_nervous | 0.94107036 |
| 82 | MP0001963_abnormal_hearing_physiology | 0.93944353 |
| 83 | MP0003631_nervous_system_phenotype | 0.89599298 |
| 84 | MP0002090_abnormal_vision | 0.89549718 |
| 85 | MP0008995_early_reproductive_senescence | 0.86794176 |
| 86 | MP0004215_abnormal_myocardial_fiber | 0.86129661 |
| 87 | MP0002069_abnormal_eating/drinking_beha | 0.85983086 |
| 88 | MP0003137_abnormal_impulse_conducting | 0.85937040 |
| 89 | MP0002152_abnormal_brain_morphology | 0.83487215 |
| 90 | MP0005195_abnormal_posterior_eye | 0.82202248 |
| 91 | MP0003879_abnormal_hair_cell | 0.81885235 |
| 92 | MP0000647_abnormal_sebaceous_gland | 0.78180944 |
| 93 | MP0002277_abnormal_respiratory_mucosa | 0.75787748 |
| 94 | MP0005535_abnormal_body_temperature | 0.73610318 |
| 95 | MP0005248_abnormal_Harderian_gland | 0.73563632 |
| 96 | MP0000427_abnormal_hair_cycle | 0.71511789 |
| 97 | MP0004085_abnormal_heartbeat | 0.70430488 |
| 98 | MP0005171_absent_coat_pigmentation | 0.68286784 |
| 99 | MP0002234_abnormal_pharynx_morphology | 0.67022232 |
| 100 | MP0003632_abnormal_nervous_system | 0.65409771 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Polyphagia (HP:0002591) | 3.65694000 |
| 2 | Medial flaring of the eyebrow (HP:0010747) | 3.62679252 |
| 3 | Focal motor seizures (HP:0011153) | 3.62293061 |
| 4 | Gait imbalance (HP:0002141) | 3.58029615 |
| 5 | Pancreatic cysts (HP:0001737) | 3.47018900 |
| 6 | True hermaphroditism (HP:0010459) | 3.41268635 |
| 7 | Pancreatic fibrosis (HP:0100732) | 3.34088936 |
| 8 | Febrile seizures (HP:0002373) | 3.32714393 |
| 9 | Congenital primary aphakia (HP:0007707) | 3.27291019 |
| 10 | Hyperventilation (HP:0002883) | 3.14427950 |
| 11 | Abnormality of midbrain morphology (HP:0002418) | 3.14369698 |
| 12 | Molar tooth sign on MRI (HP:0002419) | 3.14369698 |
| 13 | Progressive cerebellar ataxia (HP:0002073) | 3.12483819 |
| 14 | Limb dystonia (HP:0002451) | 3.11655750 |
| 15 | Nephrogenic diabetes insipidus (HP:0009806) | 3.06023235 |
| 16 | Hemiparesis (HP:0001269) | 2.94394436 |
| 17 | Focal seizures (HP:0007359) | 2.93850389 |
| 18 | Myokymia (HP:0002411) | 2.90537740 |
| 19 | Epileptic encephalopathy (HP:0200134) | 2.86865754 |
| 20 | Nephronophthisis (HP:0000090) | 2.85530894 |
| 21 | Atonic seizures (HP:0010819) | 2.85185018 |
| 22 | Absent speech (HP:0001344) | 2.72567221 |
| 23 | Genital tract atresia (HP:0001827) | 2.64104102 |
| 24 | Drooling (HP:0002307) | 2.61480038 |
| 25 | Broad-based gait (HP:0002136) | 2.60274772 |
| 26 | Renal cortical cysts (HP:0000803) | 2.60179616 |
| 27 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.58222036 |
| 28 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.58222036 |
| 29 | Abnormal eating behavior (HP:0100738) | 2.56487404 |
| 30 | Acute necrotizing encephalopathy (HP:0006965) | 2.54255955 |
| 31 | Vaginal atresia (HP:0000148) | 2.51587368 |
| 32 | Agitation (HP:0000713) | 2.51018386 |
| 33 | Lissencephaly (HP:0001339) | 2.48766397 |
| 34 | Dialeptic seizures (HP:0011146) | 2.47125422 |
| 35 | Progressive macrocephaly (HP:0004481) | 2.46674230 |
| 36 | Abnormal ciliary motility (HP:0012262) | 2.45874591 |
| 37 | Inability to walk (HP:0002540) | 2.45765398 |
| 38 | Epileptiform EEG discharges (HP:0011182) | 2.42160108 |
| 39 | Hypsarrhythmia (HP:0002521) | 2.40197626 |
| 40 | Excessive salivation (HP:0003781) | 2.39959045 |
| 41 | Abnormality of the renal cortex (HP:0011035) | 2.39645970 |
| 42 | EEG with generalized epileptiform discharges (HP:0011198) | 2.39638972 |
| 43 | Abnormality of the renal medulla (HP:0100957) | 2.37586570 |
| 44 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.37198874 |
| 45 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.37198874 |
| 46 | Type II lissencephaly (HP:0007260) | 2.35356076 |
| 47 | Mitochondrial inheritance (HP:0001427) | 2.33732267 |
| 48 | Specific learning disability (HP:0001328) | 2.33676589 |
| 49 | Absent/shortened dynein arms (HP:0200106) | 2.33654174 |
| 50 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.33654174 |
| 51 | Chronic hepatic failure (HP:0100626) | 2.30778574 |
| 52 | Split foot (HP:0001839) | 2.27379613 |
| 53 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.25674941 |
| 54 | Congenital stationary night blindness (HP:0007642) | 2.25635802 |
| 55 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.25587084 |
| 56 | Pachygyria (HP:0001302) | 2.24764811 |
| 57 | Generalized tonic-clonic seizures (HP:0002069) | 2.21763503 |
| 58 | Retinal dysplasia (HP:0007973) | 2.17615865 |
| 59 | 3-Methylglutaconic aciduria (HP:0003535) | 2.16516179 |
| 60 | Progressive inability to walk (HP:0002505) | 2.15980624 |
| 61 | Absence seizures (HP:0002121) | 2.13192540 |
| 62 | Action tremor (HP:0002345) | 2.13025426 |
| 63 | Gaze-evoked nystagmus (HP:0000640) | 2.10213550 |
| 64 | Ankle clonus (HP:0011448) | 2.09594288 |
| 65 | Poor coordination (HP:0002370) | 2.07779904 |
| 66 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.07437380 |
| 67 | Abolished electroretinogram (ERG) (HP:0000550) | 2.07043599 |
| 68 | Abnormality of the corticospinal tract (HP:0002492) | 2.06830706 |
| 69 | Genetic anticipation (HP:0003743) | 2.06732788 |
| 70 | Spastic tetraplegia (HP:0002510) | 2.06021242 |
| 71 | Cystic liver disease (HP:0006706) | 2.05326464 |
| 72 | Mutism (HP:0002300) | 2.04912908 |
| 73 | Increased CSF lactate (HP:0002490) | 2.04781094 |
| 74 | Failure to thrive in infancy (HP:0001531) | 2.02774635 |
| 75 | Acute encephalopathy (HP:0006846) | 2.01597111 |
| 76 | Poor suck (HP:0002033) | 2.00860773 |
| 77 | Decreased central vision (HP:0007663) | 1.99669191 |
| 78 | Hypothermia (HP:0002045) | 1.99036660 |
| 79 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.99034299 |
| 80 | Abnormality of alanine metabolism (HP:0010916) | 1.99034299 |
| 81 | Hyperalaninemia (HP:0003348) | 1.99034299 |
| 82 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 1.98807774 |
| 83 | Amyotrophic lateral sclerosis (HP:0007354) | 1.98515118 |
| 84 | Postaxial hand polydactyly (HP:0001162) | 1.96071484 |
| 85 | Polydipsia (HP:0001959) | 1.95251404 |
| 86 | Abnormal drinking behavior (HP:0030082) | 1.95251404 |
| 87 | Spastic gait (HP:0002064) | 1.95075371 |
| 88 | Methylmalonic acidemia (HP:0002912) | 1.94668908 |
| 89 | Short tibia (HP:0005736) | 1.93500063 |
| 90 | Attenuation of retinal blood vessels (HP:0007843) | 1.91195743 |
| 91 | Large for gestational age (HP:0001520) | 1.88847238 |
| 92 | Occipital encephalocele (HP:0002085) | 1.88493089 |
| 93 | Optic disc pallor (HP:0000543) | 1.87528454 |
| 94 | Increased hepatocellular lipid droplets (HP:0006565) | 1.84626067 |
| 95 | Rhinitis (HP:0012384) | 1.83644368 |
| 96 | Bile duct proliferation (HP:0001408) | 1.82706210 |
| 97 | Abnormal biliary tract physiology (HP:0012439) | 1.82706210 |
| 98 | Lipid accumulation in hepatocytes (HP:0006561) | 1.82309418 |
| 99 | Thyroid-stimulating hormone excess (HP:0002925) | 1.81728493 |
| 100 | Urinary urgency (HP:0000012) | 1.81228117 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MARK1 | 3.68939254 |
| 2 | MAP3K4 | 3.45847318 |
| 3 | CASK | 3.23874311 |
| 4 | MAP4K2 | 3.10372197 |
| 5 | MAP2K7 | 2.92325296 |
| 6 | FRK | 2.81063934 |
| 7 | WNK3 | 2.65748260 |
| 8 | MAPK13 | 2.47485598 |
| 9 | BCR | 2.46197951 |
| 10 | PINK1 | 2.37086595 |
| 11 | ADRBK2 | 2.26847638 |
| 12 | EPHA3 | 2.05549392 |
| 13 | TRIM28 | 2.02678970 |
| 14 | NTRK2 | 1.87716049 |
| 15 | ERBB3 | 1.87597848 |
| 16 | NTRK3 | 1.85528060 |
| 17 | DAPK2 | 1.82764571 |
| 18 | BMPR1B | 1.74828381 |
| 19 | EPHA4 | 1.72250858 |
| 20 | CSNK1G2 | 1.62394601 |
| 21 | PAK3 | 1.60963755 |
| 22 | DYRK2 | 1.60642214 |
| 23 | CSNK1G3 | 1.40045308 |
| 24 | MAP2K4 | 1.38754776 |
| 25 | CAMKK2 | 1.38637079 |
| 26 | UHMK1 | 1.36279349 |
| 27 | GRK1 | 1.32422938 |
| 28 | PLK2 | 1.31704062 |
| 29 | PRKCG | 1.28011959 |
| 30 | CSNK1A1L | 1.26915691 |
| 31 | MAPK15 | 1.25089022 |
| 32 | DYRK3 | 1.17403103 |
| 33 | INSRR | 1.15075605 |
| 34 | PAK6 | 1.14517001 |
| 35 | CSNK1G1 | 1.13789594 |
| 36 | PRKCE | 1.12515989 |
| 37 | BCKDK | 1.12085402 |
| 38 | MINK1 | 1.09338040 |
| 39 | SIK2 | 0.99777383 |
| 40 | CAMK2A | 0.96121313 |
| 41 | WNK4 | 0.91058620 |
| 42 | PKN1 | 0.88423686 |
| 43 | DYRK1B | 0.87021292 |
| 44 | CDK5 | 0.86529799 |
| 45 | LIMK1 | 0.86394297 |
| 46 | TNIK | 0.84827562 |
| 47 | SGK494 | 0.84521580 |
| 48 | SGK223 | 0.84521580 |
| 49 | PHKG1 | 0.84158001 |
| 50 | PHKG2 | 0.84158001 |
| 51 | TAOK3 | 0.83549048 |
| 52 | OXSR1 | 0.79586029 |
| 53 | CAMK2B | 0.79098371 |
| 54 | DYRK1A | 0.78903705 |
| 55 | CDK19 | 0.74742118 |
| 56 | ACVR1B | 0.69510589 |
| 57 | SGK2 | 0.67211553 |
| 58 | ADRBK1 | 0.64777784 |
| 59 | MAP3K12 | 0.63423467 |
| 60 | ZAK | 0.63095680 |
| 61 | GRK5 | 0.59226540 |
| 62 | MAPKAPK5 | 0.58293346 |
| 63 | PRKACA | 0.57995102 |
| 64 | CAMKK1 | 0.56648739 |
| 65 | TLK1 | 0.56249218 |
| 66 | MST4 | 0.55142084 |
| 67 | STK38L | 0.55120595 |
| 68 | MUSK | 0.54662969 |
| 69 | PRKCZ | 0.54553668 |
| 70 | FER | 0.54306469 |
| 71 | AKT3 | 0.51701584 |
| 72 | CAMK2D | 0.51385304 |
| 73 | CCNB1 | 0.50699542 |
| 74 | STK39 | 0.50481270 |
| 75 | MAP3K5 | 0.50380358 |
| 76 | CAMK2G | 0.49978308 |
| 77 | TESK1 | 0.48555790 |
| 78 | CAMK4 | 0.48516583 |
| 79 | RPS6KA4 | 0.48507829 |
| 80 | CDK14 | 0.48405213 |
| 81 | EPHB2 | 0.46709449 |
| 82 | FGFR2 | 0.46096127 |
| 83 | PRKG1 | 0.45913691 |
| 84 | PNCK | 0.45745049 |
| 85 | KSR1 | 0.43296727 |
| 86 | CAMK1 | 0.39573177 |
| 87 | CSNK1A1 | 0.39319338 |
| 88 | GRK7 | 0.39271953 |
| 89 | SIK3 | 0.37723196 |
| 90 | PRKACB | 0.37573727 |
| 91 | CSNK1D | 0.37376548 |
| 92 | TNK2 | 0.37255899 |
| 93 | RPS6KA5 | 0.36134331 |
| 94 | TXK | 0.36106181 |
| 95 | PRKCA | 0.35754859 |
| 96 | CDK18 | 0.35403187 |
| 97 | NUAK1 | 0.34605804 |
| 98 | PRKACG | 0.32633072 |
| 99 | MAP3K6 | 0.31920108 |
| 100 | STK11 | 0.31852104 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.88715143 |
| 2 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.93467841 |
| 3 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.84325202 |
| 4 | GABAergic synapse_Homo sapiens_hsa04727 | 2.71009954 |
| 5 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.55617165 |
| 6 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.44153516 |
| 7 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.40358818 |
| 8 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.38848785 |
| 9 | Morphine addiction_Homo sapiens_hsa05032 | 2.35730968 |
| 10 | Protein export_Homo sapiens_hsa03060 | 2.31937936 |
| 11 | Phototransduction_Homo sapiens_hsa04744 | 2.20626023 |
| 12 | Parkinsons disease_Homo sapiens_hsa05012 | 2.15407681 |
| 13 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.11935163 |
| 14 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 2.02446838 |
| 15 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.01308897 |
| 16 | Circadian entrainment_Homo sapiens_hsa04713 | 1.99915155 |
| 17 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.98348199 |
| 18 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.74877556 |
| 19 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.73330885 |
| 20 | Taste transduction_Homo sapiens_hsa04742 | 1.72446076 |
| 21 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.68037056 |
| 22 | Cocaine addiction_Homo sapiens_hsa05030 | 1.59701344 |
| 23 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.52624697 |
| 24 | Alzheimers disease_Homo sapiens_hsa05010 | 1.51533742 |
| 25 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.49822344 |
| 26 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.49085394 |
| 27 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.43483020 |
| 28 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.42359637 |
| 29 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.40448849 |
| 30 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.37554744 |
| 31 | Insulin secretion_Homo sapiens_hsa04911 | 1.35730994 |
| 32 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.34433158 |
| 33 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.33622175 |
| 34 | Huntingtons disease_Homo sapiens_hsa05016 | 1.29152920 |
| 35 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.25750208 |
| 36 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.24430104 |
| 37 | Peroxisome_Homo sapiens_hsa04146 | 1.21195987 |
| 38 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.20675217 |
| 39 | Circadian rhythm_Homo sapiens_hsa04710 | 1.13428841 |
| 40 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.08699345 |
| 41 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.08020898 |
| 42 | Olfactory transduction_Homo sapiens_hsa04740 | 1.04769674 |
| 43 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.04208700 |
| 44 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.04207086 |
| 45 | Long-term depression_Homo sapiens_hsa04730 | 1.02409462 |
| 46 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.01895712 |
| 47 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.01356520 |
| 48 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.97630062 |
| 49 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.95603349 |
| 50 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.90186145 |
| 51 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.86174859 |
| 52 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.83484979 |
| 53 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.83315239 |
| 54 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.82436249 |
| 55 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.82269311 |
| 56 | Renin secretion_Homo sapiens_hsa04924 | 0.80396040 |
| 57 | Salivary secretion_Homo sapiens_hsa04970 | 0.80293202 |
| 58 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.72715018 |
| 59 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.72056001 |
| 60 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.69386176 |
| 61 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.68730212 |
| 62 | Axon guidance_Homo sapiens_hsa04360 | 0.68273774 |
| 63 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.66467906 |
| 64 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.65729868 |
| 65 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.64629794 |
| 66 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.63055165 |
| 67 | ABC transporters_Homo sapiens_hsa02010 | 0.62770752 |
| 68 | Basal transcription factors_Homo sapiens_hsa03022 | 0.59520494 |
| 69 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.59455467 |
| 70 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.58159956 |
| 71 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.55998458 |
| 72 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.54253015 |
| 73 | Histidine metabolism_Homo sapiens_hsa00340 | 0.53624827 |
| 74 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.51829173 |
| 75 | Retinol metabolism_Homo sapiens_hsa00830 | 0.50462788 |
| 76 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.49903877 |
| 77 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.46969541 |
| 78 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.45568648 |
| 79 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.43787265 |
| 80 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.43648038 |
| 81 | Phagosome_Homo sapiens_hsa04145 | 0.43000895 |
| 82 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.41932250 |
| 83 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.41537456 |
| 84 | Metabolic pathways_Homo sapiens_hsa01100 | 0.40290059 |
| 85 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.39376480 |
| 86 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.38316827 |
| 87 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.37835153 |
| 88 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.37663663 |
| 89 | Alcoholism_Homo sapiens_hsa05034 | 0.37032636 |
| 90 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.36214394 |
| 91 | Gap junction_Homo sapiens_hsa04540 | 0.33315786 |
| 92 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.32354040 |
| 93 | Long-term potentiation_Homo sapiens_hsa04720 | 0.30221432 |
| 94 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.28639397 |
| 95 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.28500143 |
| 96 | Mineral absorption_Homo sapiens_hsa04978 | 0.27477311 |
| 97 | RNA polymerase_Homo sapiens_hsa03020 | 0.27384238 |
| 98 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.26535298 |
| 99 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.25765190 |
| 100 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.22147584 |

